Illumina Launches Two New Sequencing Platforms

Illumina Launches the NextSeq™ 500 Sequencing System

Transformative Addition to Industry-Leading Portfolio Brings Whole Genome Sequencing to the Desktop

SAN DIEGO–(BUSINESS WIRE)–Jan. 14, 2014– Illumina, Inc. (NASDAQ:ILMN) today announced the immediate availability of a transformative addition to its industry-leading next-generation sequencing portfolio with the launch of the NextSeq 500 System. The new sequencer packs high-throughput performance into an affordable desktop form factor, enabling researchers to perform the most popular sequencing applications in less than a day. The NextSeq 500 System is priced at $250,000.

rna-seqThe NextSeq™ 500 System, capable of sequencing a whole human genome in a single run, delivers the power of high-throughput sequencing with the simplicity of a desktop sequencer, enabling everyday genomics. (Photo: Business Wire)

“Illumina’s sequencing portfolio is the most comprehensive in the world, and the addition of the NextSeq 500 System furthers this distinction by enabling next-generation sequencing to become an everyday tool,” said Jay Flatley, CEO of Illumina. “The NextSeq 500 was reimagined from the ground up and uses technology breakthroughs in optics, fluidics and chemistry to bring high throughput power to the desktop at a significantly reduced cost.” (read more…)

Illumina Introduces the HiSeq X™ Ten Sequencing System

Breaks Barriers with World’s First $1,000 Genome, Enables ‘Factory’ Scale Sequencing for Population and Disease Studies

SAN DIEGO–(BUSINESS WIRE)–Jan. 14, 2014– Illumina, Inc. (NASDAQ:ILMN) today broke the ‘sound barrier’ of human genomics by enabling the $1,000 genome. This achievement is made possible by the new HiSeq X Ten Sequencing System. This platform includes dramatic technology breakthroughs that enable researchers to undertake studies of unprecedented scale by providing the throughput to sequence tens of thousands of human whole genomes in a single year in a single lab. Initial customers for the transformative HiSeq X Ten System include Macrogen, a global next-generation sequencing service organization based in Seoul, South Korea and its CLIA laboratory in Rockville, Maryland, the Broad Institute in Cambridge, Massachusetts, the world’s leading research institute in genomic medicine, and the Garvan Institute of Medical Research in Sydney, Australia, a world leader in biomedical research.

rna-seqThe HiSeq X™ Ten, composed of 10 HiSeq X Systems, is the first sequencing platform that breaks the $1000 barrier for a 30x human genome. The HiSeq X Ten System is ideal for population-scale projects focused on the discovery of genotypic variation to understand and improve human health. (Photo: Business Wire)

“The sequencing capacity and economies of scale of the HiSeq X Ten facility will also allow Garvan to accelerate the introduction of clinical genomics and next-generation medicine in Australia,” said Professor John Mattick, Executive Director of the Garvan Institute of Medical Research. “We expect the HiSeq X Ten to underpin a new phase of collaboration between government, industry and other medical research stakeholders.”

“For the first time, it looks like it will be possible to deliver the $1,000 genome, which is tremendously exciting,” said Eric Lander, founding director of the Broad Institute and a professor of biology at MIT. “The HiSeq X Ten should give us the ability to analyze complete genomic information from huge sample populations. Over the next few years, we have an opportunity to learn as much about the genetics of human disease as we have learned in the history of medicine.” (read more…)